Live feed01:00:00·1594dPRReleasevia QuantisnowIpsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global PartnershipByQuantisnow·Wall Street's wire, on your screen.GNFT· GENFIT S.A.Health Care
